According to Assertio Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.7100.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.7340 | -20.21% |
2022-12-31 | 0.9200 | -3.17% |
2021-12-31 | 0.9501 | 37.56% |
2020-12-31 | 0.6907 | -60.41% |
2019-12-31 | 1.74 | 65.89% |
2018-12-31 | 1.05 | -64.86% |
2017-12-31 | 2.99 | -32.37% |
2016-12-31 | 4.42 | 26.49% |
2015-12-31 | 3.50 | 33.46% |
2014-12-31 | 2.62 | -40.66% |
2013-12-31 | 4.42 | 6.23% |
2012-12-31 | 4.16 | 53.47% |
2011-12-31 | 2.71 | -81.41% |
2010-12-31 | 14.6 | 31.09% |
2009-12-31 | 11.1 | 337.62% |
2008-12-31 | 2.54 | -25.87% |
2007-12-31 | 3.43 | -164.51% |
2006-12-31 | -5.31 | -114.61% |
2005-12-31 | 36.4 | 63.16% |
2004-12-31 | 22.3 | 214.49% |
2003-12-31 | 7.09 | -238.1% |
2002-12-31 | -5.13 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.6522 | -8.13% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 1.96 | 175.91% | ๐บ๐ธ USA |